| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
ABAT won its appeal to reinstate a $115 million DOE grant for a commercial-scale critical mineral lithium refinery, reversing the prior loss that had knocked down the stock price. The restoration of this key funding catalyst should support recovery and upside.
ABAT is showing operational turnaround with Q3 revenue jumping to $7.8M and first positive gross margin, combined with a massive valuation disconnect: the company's Tonopah Flats lithium project alone carries a $2.57B NPV while the stock trades at a ~$500M market cap, offering substantial upside even after accounting for execution risk, dilution, and capital burn.
End of results.